Source: Annual Congress 2010 - Experimental pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Veit, M. Roth, B. Egemnazarov, H. A. Ghofrani, R. T. Schermuly, W. Seeger, F. Grimminger, N. Weissmann (Giessen, Bad Nauheim, Germany). NOX1 derived generation of reactive oxygen species in monocrotaline-induced pulmonary arterial hypertension of rats. Eur Respir J 2010; 36: Suppl. 54, 1063

Member's Comments

No comment yet.

Related content which might interest you: Increased generation of reactive oxygen species in pulmonary arterial smooth muscle cells, isolated from monocrotaline-treated rats Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases Year: 2009 Reactive oxygen species production by rat neutrophils in pulmonary arterial hypertension experimental model Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 MnTBAP reduces pulmonary vascular remodeling in experimental pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 The role of reactive oxygen species in pulmonary inflammation Source: Eur Respir J 2003; 22: Suppl. 45, 531s Year: 2003 TRAM-34 ameliorates hypoxia-induced pulmonary arterial hypertension in rats Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Two rat models of hemolysis-induced pulmonary hypertension Source: Annual Congress 2010 - Experimental pulmonary hypertension Year: 2010 ACE2 activation improves pulmonary endothelial function and attenuates monocrotaline-induced pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Targeting of mitochondrial superoxide in chronic hypoxia-induced pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Cirrhosis ameliorates monocrotaline-induced pulmonary hypertension in rats Source: Eur Respir J 2009; 34: 731 Year: 2009 Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms Source: Eur Respir J 2008; 32: 1639-1651 Year: 2008 The ROS controversy in hypoxic pulmonary hypertension revisited Source: Eur Respir J, 51 (3) 1800276; 10.1183/13993003.00276-2018 Year: 2018 Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019 Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Early atorvastatin administration suppresses the oxygen-activating ability of rat neutrophils during monocrotalinin-induced pulmonary arterial hypertension (PAH). Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 Pathways in pulmonary arterial hypertension: the future is here Source: Eur Respir Rev 2012 21: 321-327 Year: 2012 Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension Source: Eur Respir J, 56 (5) 2000522; 10.1183/13993003.00522-2020 Year: 2020 The role of superoxide in hypoxic pulmonary vasoconstriction in chronically hypoxic rat lungs Source: Eur Respir J 2004; 24: Suppl. 48, 95s Year: 2004 Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension Source: Eur Respir J 2010; 36: 1483-1485 Year: 2010